Growth Metrics

Outlook Therapeutics (OTLK) Non-cash Items: 2019-2020

  • Outlook Therapeutics' Non-cash Items was N/A to $2.1 million in Q2 2020 from the same period last year, while for Jun 2020 it was $2.1 million, marking a year-over-year change of. This contributed to the annual value of $2.5 million for FY2019, which is N/A change from last year.
  • Outlook Therapeutics' Non-cash Items amounted to $2.1 million in Q2 2020, which was down 13.20% from $2.4 million recorded in Q1 2020.
  • Over the past 5 years, Outlook Therapeutics' Non-cash Items peaked at $3.3 million during Q4 2019, and registered a low of $2.1 million during Q2 2020.
  • Its 2-year average for Non-cash Items is $2.6 million, with a median of $2.5 million in 2019.